866-997-4948(US-Canada Toll Free)

Stem Cell Research

Published By :

RI Technologies

Published Date : Jul 2013

Category :

Diabetes

No. of Pages : 824 Pages


This report on Stem Cell Research gives a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells and Other. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Orthopedics, Oncology, Hematology, Cardiology, Dermatology, Diabetes, Hepatology and Other. Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 59 major companies are discussed in the report. The report serves as a guide to global Stem Cell industry covering more 650 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. The report also gives a comprehensive global list of 200+ cord blood/stem cell banks. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Compilation of Worldwide Patents and Research related to Stem Cell Research is also provided.
Table of Content

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS
Foreword
Stem Cells
Exhibit 1.Evolution of Stem Cell Research
Segmentation of Stem Cell Research Market
Exhibit 2.Segmentation of Global Stem Cells Market by Stem Cell Type, Technology & Therapeutic Area
Stem Cell Type
Adult Stem Cells
Cord Blood Stem Cells
Embryonic Stem Cells
Technology
Stem Cell Transplantation
Cell based Genomics
Xenotransplantation
Cord Blood Banking
Therapeutic Area
Neurology
Orthopedics
Oncology
Hematology
Cardiology
Dermatology
Diabetes
Hepatology
Stem Cell Research - Global Market Analysis
Exhibit 3.Stem Cell Research – Global Market Estimations & Predictions (2005 -2020) in US$ Million  (Graphical Representation Included) 
Exhibit 4.List of Global Major Stem Cell Companies

III. MARKET DYNAMICS
Market Overview
Global Market Analysis
Analysis by Region
Exhibit 5. Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 6. Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 7. Stem Cell Research - Global Investments (2005 -2020) in US$ Million (Graphical Representation Included) 
North American Stem Cells Market
Exhibit 8. Stem Cell Research – North American Market Estimations & Predictions (2005 - 2020) in  US$ Million for United States and Canada (Graphical Representation Included) 
Exhibit 9. Stem Cell Research – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 
United States Stem Cells Market
US Market Scenario
Setback for hESC Development
The President\'s Criteria
NIH Cannot Fund Embryonic Stem Cell Research, Judge Rules
Embryonic Stem Cell Research Ban Withdrawn in the US
The Role of the NIH
First Human Clinical Trial of Stem Cell Therapy approved by FDA
The US Backs Stem Cell Research
Exhibit 10. Stem Cell Research - United States Investments (2005 – 2020) in US$ Million (Graphical Representation Included) 
Exhibit 11. List of Cord Blood/ Stem Cell Banks in the United States
Canadian Stem Cells Market
Canadian Market Scenario
Guidelines for Stem Cell Research
Canadian Cord Blood Banking Sector
Exhibit 12. List of Cord Blood/ Stem Cell Banks in Canada
Exhibit 13. List of Major North American Stem Cells Companies
European Stem Cells Market
Funding for Stem Cell Research in Europe
Cord Blood Banking in Europe
Exhibit 14. Stem Cell Research – European Market Estimations & Predictions (2005 - 2020) in US$ Million for United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe (Graphical Representation Included) 
Exhibit 15. Stem Cell Research – European Market Shares (2010, 2015 & 2020) for United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe (Graphical Representation Included) 
UK Stem Cells Market
UK Market Scenario
UK Cord Blood Banking Sector
Exhibit 16. List of Cord Blood/ Stem Cell Banks in the UK
German Stem Cells Market
German Market Scenario
Exhibit 17. List of Cord Blood/ Stem Cell Banks in Germany
French Stem Cells Market
French Market Scenario
Cord Blood Banking in France
Exhibit 18. List of Cord Blood/ Stem Cell Banks in France
Spanish Stem Cells Market
Spanish Market Scenario
Exhibit 19. List of Cord Blood/ Stem Cell Banks in Spain
Russian Stem Cells Market
Russian Market Scenario
Exhibit 20. List of Cord Blood/ Stem Cell Banks in Russia
Swedish Stem Cells Market
Swedish Market Scenario
Swiss Stem Cells Market
Swiss Market Scenario
Exhibit 21. List of Cord Blood/ Stem Cell Banks in Switzerland
Exhibit 22. List of Major European Stem Cells Companies
Market Analysis for Select Rest of Europe Countries
Exhibit 23. Stem Cell Research – Rest of Europe Market Estimations & Predictions (2005 - 2020) in US$ Million for Belgium, Denmark, Poland, Austria and Greece (Graphical Representation Included) 
Exhibit 24. Stem Cell Research – Rest of Europe Market Shares (2010, 2015 & 2020) for Belgium, Denmark, Poland, Austria and Greece (Graphical Representation Included) 
Exhibit 25. List of Cord Blood/ Stem Cell Banks in Rest of Europe
Belgium
Belgian Market Scenario
Denmark
Danish Market Scenario
Exhibit 26. Stem Cell Bank in Denmark
Poland
Polish Market Scenario
Exhibit 27. List of Cord Blood/ Stem Cell Banks in Poland
Austria
Austrian Market Scenario
Exhibit 28. List of Cord Blood/ Stem Cell Banks in Austria
Greece
Greek Market Scenario
Exhibit 29. List of Cord Blood/ Stem Cell Banks in Greece
Asia-Pacific Stem Cells Market
Exhibit 30. Stem Cell Research – Asia-Pacific Market Estimations & Predictions (2005 - 2020) in US$ Million for Japan, India, China, Australia, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 
Exhibit 31. Stem Cell Research –Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, India, China, Australia, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 
Japanese Stem Cells Market
Japanese Market Scenario
Exhibit 32. List of Cord Blood/ Stem Cell Banks in Japan
Exhibit 33. List of 11 Cord Blood Banks that forms Japan Cord Blood Bank Network (JCBBN) 
Indian Stem Cells Market
Indian Market Scenario
The Indian Cord Blood Banking Sector
Exhibit 34. List of Cord Blood/ Stem Cell Banks in India
Chinese Stem Cells Market
Chinese Market Scenario
Exhibit 35. List of Cord Blood/ Stem Cell Banks in China
Australian Stem Cells Market
Australian Market Scenario
Exhibit 36. List of Cord Blood/ Stem Cell Banks in Australia
South Korean Stem Cells Market
South Korean Market Scenario
National Stem Cell Bank
CARTISTEM – World’s First Approved Stem Cell Drug for Degenerative Arthritis
President’s Promise to Fund Stem Cell Research
Hearticellgram-AMI
The South Korean Cord Blood Banking Sector
KRIBB
Chaum Life Center
Exhibit 37. List of Cord Blood/ Stem Cell Banks in South Korea
Exhibit 38. List of Major Asia-Pacific Stem Cells Companies
Analysis of Select Rest of Asia-Pacific Countries
Exhibit 39. Stem Cell Research – Rest of Asia-Pacific Market Estimations & Predictions (2005 - 2020) in US$ Million for Hong Kong, Taiwan, New Zealand, Malaysia and Singapore (Graphical Representation Included) 
Exhibit 40. Stem Cell Research – Rest of Asia-Pacific Market Shares (2010, 2015 & 2020) in US$ Million for Hong Kong, Taiwan, New Zealand, Malaysia and Singapore (Graphical Representation Included) 
Exhibit 41. List of Cord Blood/ Stem Cell Banks in Rest of Asia-Pacific
Hong Kong
Hong Kong Market Analysis
Exhibit 42. List of Cord Blood/ Stem Cell Banks in Hong Kong
Taiwan
Taiwanese Market Scenario
Exhibit 43. List of Cord Blood/ Stem Cell Banks in Taiwan
New Zealand
New Zealand Market Scenario
Exhibit 44.Cord Blood Bank in New Zealand
Malaysia
Malaysian Market Scenario
Singapore
Singaporean Market Scenario
Exhibit 45. List of Cord Blood/ Stem Cell Banks in Singapore
Rest of World Stem Cell Research Market
Exhibit 46. Stem Cell Research – Rest of World Market Estimations & Predictions (2005 - 2020) in US$ Million for Latin America, Middle East and South Africa (Graphical Representation Included) 
Exhibit 47.Stem Cells– Rest of World Global Market Shares (2010, 2015 & 2020) for Latin America, Middle East and South Africa (Graphical Representation Included) 
Exhibit 48. List of Major Companies in Rest of World
Latin American Stem Cells Market
Latin American Market Scenario
Exhibit 49. Stem Cell Research – Latin American Market Estimations & Predictions (2005 - 2020) in US$ Million for Brazil, Colombia, Mexico, Argentina and Rest of Latin America (Graphical Representation Included) 
Exhibit 50. Stem Cell Research – Latin American Market Shares (2010, 2015 & 2020) by for Brazil, Colombia, Mexico, Argentina and Rest of Latin America (Graphical Representation Included) 
Mexico
Mexican Market Scenario
Exhibit 51. List of Cord Blood/ Stem Cell Banks in Mexico
Brazil
Brazilian Market Scenario
Exhibit 52. List of Cord Blood/ Stem Cell Banks in Brazil
Colombia
Colombian Market Scenario
Exhibit 53.Cord Blood Bank in Colombia
Argentina
Argentinean Market Scenario
Exhibit 54. List of Cord Blood/ Stem Cell Banks in Argentina
Rest of Latin America
Rest of Latin America Market Analysis
Exhibit 55. Cord Blood/ Stem Cell Banks in Rest of Latin America
Middle East Stem Cells Market
Exhibit 56. Stem Cell Research – Middle East Market Estimations & Predictions (2005 - 2020) in US$ Million for Israel and Rest of Middle East (Graphical Representation Included) 
Exhibit 57. Stem Cell Research –Middle East Market Shares (2010, 2015 & 2020) by for Israel and Rest of Middle East (Graphical Representation Included) 
Israel
Israeli Market Scenario
Exhibit 58. List of Cord Blood/ Stem Cell Banks in Israel
Rest of Middle East
Rest of Middle East Market Analysis
Rest of Middle East Market Scenario
Exhibit 59. List of Cord Blood/ Stem Cell Banks in Rest of Middle East
African Stem Cells Market
South African Market Analysis
South African Market Scenario
Exhibit 60. List of Cord Blood/ Stem Cell Banks in South Africa
1. Stem Cell Research - Trends
Stem Cell Therapy of Pets
Nobel Prize
In 2012, Prof. Shinya Yamanaka of Japan and Prof. John B. Gurdon of the United Kingdom shared the Nobel Prize for the discovery that mature cells can be reprogrammed to become pluripotent. 
Setback for hESC Development
NIH Cannot Fund Embryonic Stem Cell Research, Judge Rules
New Method of Developing hESC Lines without Killing Human Embryos Discovered
Future of Cloned Food
Adult Stem Cells to Play Key Role in Heart Diseases
Use of Robotics in Stem Cell Research Automation
Identification of New Stem Cell with Dual Characteristics
Stem Cell Derivation from a Single Cell Extracted from Early Human Embryos
Reprogramming of Adult Stem Cells
Adult Stem Cells - Free of Controversy and Yield Better Results
Select Global Stem Cell Research Centers
2. Company Profiles - Major Companies in Stem Cell Research Market
Aastrom Biosciences, Inc. (USA) 
Advanced Cell Technology, Inc. (USA) 
ArunA Biomedical, Inc. (USA) 
Athersys, Inc. (USA) 
Axiogenesis AG (Germany) 
Beike Biotechnology Co. , Ltd. (China) 
BioE, Inc. (USA) 
Bio-Master Co. , Ltd. (Japan) 
BioTime, Inc. (USA) 
BrainStorm Cell Therapeutics, Inc. (USA) 
California Stem Cell, Inc. (USA) 
Cell Care Pty. Ltd. (Australia) 
Cellartis AB (Sweden) 
Cellerant Therapeutics, Inc. (USA) 
CellResearch Corporation Pte. , Ltd. (Singapore) 
Cells4Life Ltd. (UK) 
Cellular Dynamics International, Inc. (USA) 
CordLife Ltd. (Singapore) 
Cryo-Cell International, Inc. (USA) 
Cryo-Save Group NV (The Netherlands) 
Cryo-Save South Africa (South Africa) 
Cytomedix, Inc. (USA) 
Cytori Therapeutics, Inc. (USA) 
EMD Millipore (USA) 
Fate Therapeutics, Inc. (USA) 
Epistem Holdings PLC (UK) 
Gamida Cell Ltd. (Israel) 
GE Healthcare (UK) 
Geron Corporation (USA) 
Histostem Co. , Ltd. (South Korea) 
International Stem Cell Corporation (USA) 
iPierian, Inc. (USA) 
Life Technologies Corporation (USA) 
LifebankUSA (USA) 
LifeCell Corporation (USA) 
MEDIPOST Co. , Ltd. (South Korea) 
Mesoblast Ltd. (Australia) 
Minerva Biotechnologies (USA) 
Neuralstem, Inc. (USA) 
NeuroGeneration, Inc. (USA) 
Novartis AG (Switzerland) 
Novo Nordisk A/S (Denmark) 
Osiris Therapeutics, Inc. (USA) 
Pluristem Therapeutics, Inc. (Israel) 
Q Therapeutics, Inc. (USA) 
ReInnervate Ltd. (UK) 
Reliance Life Sciences (India) 
ReNeuron Group PLC (UK) 
RhinoCyte, Inc. (USA) 
RNL BIO Co. , Ltd. (South Korea) 
Roslin Cells Limited (UK) 
SanBio, Inc. (USA) 
Stem Cell Technology Research Center (Iran) 
Stem Cell Therapeutics Corporation (Canada) 
STEMCELL Technologies, Inc. (USA) 
StemCells, Inc. (USA) 
Stemedica Cell Technologies, Inc. (USA) 
Takara Bio, Inc. (Japan) 
ThermoGenesis Corporation (USA) 
TiGenix NV (Belgium) 
VetCell (UK) 
ViaCord LLC (USA) 
ViaCyte, Inc. (USA) 
VistaGen Therapeutics, Inc. (USA) 
Zellwerk GmbH (Germany) 
3. Major Activities in Stem Cell Research Market
ViaCyte Inc. Generates $ 10. 6 Million in a Private Sponsorship
Canada and Japan Come Together for Epigenetics of Stem Cells Research
Embryonic Stem Cell Research Unbanned in France
ThermoGenesis Unifies with Stem Cell Company
SynGen Permitted by US FDA to Market Stem Cell Therapy Products
International Market for Re-Load’s Nutraload Stem Cell Product Exceeds 3 Times the Initial Estimation
Americord Releases Sibling Cord Blood Reimbursement Policy
apceth Enters into Collaboration with Cytolon
apceth Receives Approval for first Ever Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for Cancer Treatment
Stemedica Signs Worldwide Distribution Agreement with Life Technologies
Pall Collaborates with CMDG to Provide Innovative Cord Blood Processing Technology
Plasticell and Progenitor Labs Seed Cell Treatment Endeavours in Progress at the Stevenage Bioscience Catalyst Open Innovation University Grounds
VistaGen Therapeutics and Duke University Publish Outcomes on Production of Functional 3D Human Heart Tissue
EMD Millipore Commences OsteoMAX –XF – a Fully Defined Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium after Obtaining License from Plasticell
Vitro Biopharma and Neuromics Expands Collaboration to Target Drug Discovery and Regenerative Medicine Markets
Cell Cure Neurosciences Receives Financing from the Israeli OCS and a Bio Time Inc. 
Coalition for the Advancement of Medical Research (CAMR) Transfers Mission and Assets to Alliance for Regenerative Medicine (ARM) 
Stem Cell Therapeutics Corporation Issues Restricted Rights to Clinical Cancer Stem Cell Program
StemCells to Receive US$ 19. 3 Million from California Institute for Alzheimer’s Disease Treatment
Cellular Dynamics International Establishes Facility in California, to Deduce Bank Human Induced Pluripotent Stem Cells
VistaGen Therapeutics Enters into a Partnership with Celsis to Develop LiverSafe 3D
Cellectis and Stemgent Partner to Give Conventional Genome-Engineered iPS Cell
Histogen Establishes PUR Biologics, a Joint Venture to Develop Next-Generation Biologic Solutions in Orthopedic Applications
Mesoblast Decides to Raise $170million to Drive Advanced Programs To Commercial Outcomes by Collaborative Research
Medipost to Commence Cord Blood Cell Banking in Japan
STEMSOFT Teams Up with the Canadian Blood and Marrow Transplant Group
Stem Cell Therapeutics Unites with Reneu and Nexgen
National Institutes of Health Centre for Regenerative Medicine Signs Contract with Lonza to Develop Research Grade iPSCs
SCT Signs a Merger Agreement with Trillium
Stem Cell Therapeutics Announces Joint-Venture Agreement
Medipost to Establish Corporate Body in Hong Kong
TiGenix Effectively Renews GMP License for its Stem Cell Manufacturing Facility in Madrid
Thermogenesis Decides to Sell Thermoline Product line to Helmer Scientific
Geron to Divest Stem Cell Assets
TiGenix Secures Renewal of GMP License for Stem Cell Manufacturing Facility in Madrid
SanBio Completes Enrollment of 2nd Dose Group of Patients for Clinical Trial of Stem Cell Therapy for Chronic Stroke
A New Company uses Regenerative Medicine to Corneal Transplantation
Verastem Enters Biomarker Agreement with LabCorp for Cancer Stem Cell Agent Companion Diagnostic
Cellular Dynamics and AstraZeneca Enter into Agreement to utilize iPSC-derived Human Cells in Drug Discovery Research
ReproCell Opens Office in Boston to Expand to US
GE Healthcare Life Sciences Starts A new £3 million Laboratories for Cell Science in Cardiff, Wales
Medipost Selected as the Largest Research Institute for Government Funding in the Field of Stem Cell Research
Roche and the Innovative Medicines Decides to Collaborate for Developing a Drug Based on Nobel Prize-winning Stem Cell Technology
The University College of London and Cellectis in Collaboration Agreement for Development of a T-cell Adoptive Immunotherapy to Treat Leukemia
Joint Study by Stemedica and Scripps Research Institute to Assess the Therapeutic Effect of Ischemia Tolerant Human Mesenchymal Stem Cells (itMSC) and Stem Cell Factors in Lung Injury and Sepsis
Cytomedix Enters Collaboration to Study Pioneering Bright Cell Therapy for Peripheral Arterial Disease
OGI extends financial support to TRT for carrying out studies based on Stem Cell Technology
Pets Best Insurance covers Regenerative Stem Cell Therapy
MCW’s Stem Cell Therapeutics Outcomes Database Contract Renewal by Federal Government
International Stem Cell Corporation Announces Significant Progress towards Clinical Development
Umbilical Cord Cells are More Effective than Bone Marrow Cells
SCT enters into an Agreement with UHN and MaRS Innovation for a new, Clinical-Stage, Cancer Stem Cell Program
CHA Group Enters into a MOU with DISC Sports and Spine Center
Neural-like Stem Cells from Muscle Tissue may help in Carrying out Cell Therapy for Neurodegenerative Diseases
Cord Blood Registry Named Bioscience Company of the Year
Medistem Alliances with Superview Biotechnology on Development of Therapeutics Employing Antibody and Stem Cell Technology
Lonza and OncoMed Pharmaceuticals have signed a Process Development and Manufacturing Contract and Multi-product GS License Agreement for Anti-cancer Treatment
Vitrolife takes over Cryo Management Ltd
ThermoGenesis Signs Agreement With Golden Meditech Holdings Limited for its AXP® Product range for Purchase and Distribution
Lonza enters into License with iPS Academia Japan
Stemgent Acquires Human Tissue Business of Asterand
CeeTox and Cellular Dynamics Collaborate to Offer Predictive In-Vitro Test for Cardiotoxicity Utilizing Human iPSC-derived Cells
Plasticell and EMD Millipore Agrees to Distribute fully Defined, Xeno-Free Mesenchymal Stem Cell Differentiation Media
Pluristem and World-renowned Charité Berlin-Brandenburg Center for Regenerative Therapies Renew Five-Year Collaborative research Agreement
Pluristem Therapeutics Set to Enter Bone Marrow Disease market as it is Preparing to Apply for Orphan Drug Status with FDA for the treatment of Aplastic Bone Marrow
Celebrities Support the Initiative to Increase Organ and Stem Cell Donations
Scientists Reveal the effectiveness of Stem Cell Therapy in Treating Liver Cirrhosis
Medistem and Shanghai Jia Fu Medical Initiates a Clinical Trial on Critical Limb Ischemia patients
BGI, GE Healthcare Associate on Initiating Stem Cell Science Projects
CIC NanoGUNE and Inbiomed Merge Stem Cells and Nanotechnology
Plasticell Agrees to Provide Veritas an Exclusive Distribution Rights in Japan
MCW Inks a Partnership Agreement with Primorigen for Developing Novel Stem Cell Applications
Stemgent and iPS Academia Japan, Inc, Enter into Global Patent License Agreement
Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
AuxoCell Laboratories Licenses Umbilical Cord Tissue Stem Cell Service to Brazil’s CordVida
AlloSource Expands National Presence through New Partnership with Non-Profit Tissue Bank, LifeGift
KRIBB to Initiate Research Infrastructure for Xeno-Transplantation R&D
Fibrocell Science Inc Declares a License Contract with UCLA on Dermal Cell Research to further the Development of Personalized Cell Therapies
Fibrocell Science Technology helps to Discover Two Rare Adult Stem Cell like Subpopulations in Human Skin
Regulated development of Stem Cells
ReNeuron Enters into Cell Manufacturing Contract to Complete Stroke Clinical Trial. Recruitment of Patients for the Remaining Two Dose Cohorts on Track
Affymetrix and ScreenCell Enter Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology
$1-million to advance U-M Depression Center\'s Stem Cell research into bipolar disorder
WiCell Teams with Agilent Technologies to Offer High-Resolution CGH+SNP Microarray Service
AuxoCell Laboratories Licenses Umbilical Cord Tissue Stem Cell Service to Portuguese Company Crioestaminal
Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary -- Regen BioPharma Inc. , Secures $20,000,000 in Institutional Funding
DaVinci Biosciences & Cellteam Biotechnology Combine Their Knowledge in the Stem Cell Field
VistaGen Therapeutics Enters into Agreement with Vala Sciences for Strategic Drug Screening
Cellular Dynamics Expands Distribution Agreement with iPS Academia Japan, Inc. to Include Distribution of iCell Neurons and iCell Endothelial Cells in Japan
Large-scale Stem Cell Cultivation Partnership Formalized
REMEDI to work with Chinese Universities
Stem Cells Inc. gives license to genOWay for gene insertion technology for genetically engineered mice
VistaGen Therapeutics Enhances its Drug Rescue Opportunities as a Result of an Agreement with Cato BioVentures and Cato Research
Baxter Completes Acquisition of Synovis
Lonza and Eclipse Therapeutics Entered into Developing and Production Contract
Stemina Awarded Third Phase I SBIR
Cytomedix Acquires Aldagen to Expand Regenerative Medicine Portfolio
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute’s Adipose Cell Technology
Pioneering Clinical Trials Study Cord Blood Stem Cells for Treatment of Brain Injury and Hearing Loss
Plasticell Agrees to Collaborate with Pfizer, Cellzome and University of Sheffield in a £1. 4 Million Technology Strategy Board-funded Stem Cell Project
Cellartis is Partner in InnovaLiv, a Major Multinational Regenerative Medicine Project Funded by the European Commission
UCSF and GE Healthcare team Decides to Collaborate inCord Blood Project
BioTime Licenses Technology for Vital Regulatory Gene Fundamental to Cancer and Stem Cell Reprogramming from the Wistar Institute
LoneStar Heart Acquires Exclusive Global Rights to New Class of Small Molecules with Potential for New Treatments for Diabetes
BioTime Enters into Agreement with USCN Life Science to Source Antibody-Based Products
PerkinElmer\'s ViaCord® Cord Blood Banking Business Collaborates with Miracle Babies to Improve Collection of Stem Cells from Premature Births for Potential Therapeutic Use
ThermoGenesis Signs Res-Q System Distribution Agreement with Arthrex
PerkinElmer Acquires Caliper Life Sciences
RNL Inaugurates Globally Largest Stem Cell Medical Center in Beijing, China
Medical Research Council Reconfirms Investment in Stem Cell Research
Cellectis Acquires Cellartis, to Focus on Personalized Medicine
Athersys and Fast Forward to Collaborate for the Development of MultiStem
NeoStem Acquires Amorcyte
UK-Israel to Establish Fellowship Exchange in Regenerative Medicine
California Stem Cell Acquires Cancer Stem Cell Therapy Program
Medistem Inc. Collaborates on Nanoparticle siRNA Finding in Therapy for Ischemic Conditions
Cassidy Medical Supply Teams Up with Provia Labs to offer Store-A-Tooth™ Dental Stem Cell Banking Facilities
Ysios-backed Cellerix and TiGenix Complete Merger
BioTime in Global License Agreement with Cornell University for Development and Commercialization of Vascular Cells Derived from Human Embryonic Stem Cells
Cedars-Sinai Establishes New Core Facility to Manufacture Induced Pluripotent Stem Cells
OncoCyte Corporation Expands Cancer Programs with US$10 Million Equity Financing
NeoStem Has Received Over US$1,700,000 in DOD Funding for its VSEL™ Technology Being Developed for Treating Osteoporosis
Plasticell Delivers Differentiation Protocols to Stemnion Inc. 
ArunA Biomedical in Co-Marketing Agreement with HemoGenix
ReNeuron and Angel Biotechnology Enter New Manufacturing Agreement for ReN001
MultiCell Technologies, Inc. and University Health Network Work On the Evaluation of Two Potential Therapies for Liver Cancer Therapy
Arteriocyte and US Army Institute of Surgical Research (USAISR) Enters into CRADA to Accelerate the Cellular Therapies for Orthopaedic Trauma
ReNeuron Enters into Licensing Agreement with Schepens Eye Research Institute for Development of Stem Cell Therapies for Diseases of the Retina
Shire Completes Acquisition of Advanced BioHealing Inc. 
Cord Blood America Buys NeoCells Inc’s Assets
Cryo-Cell Enters into Latin American Market
ATCC and iPS Academia Japan in Patent Licensing Agreement for Distribution of iPS Cells and iPS Cell-derived Cells
Cryo-Save and Lazaron Biotechnologies Establish Joint Venture on Stem Cell Bank in South Africa
iPS Academia Japan, Inc. to Distribute iCell® Products of Cellular Dynamics in Japan
Transposagen Inks Collaboration Agreement with SBI
NeoStem Signs Agreement with Nankai Hospital in Tianjin to Offer NeoStem\'s Licensed Orthopedic Technology
Cytori to Establish StemSource® Cell Bank for Neo Derm in Hong Kong
Takeda Ventures Strategically Invests in Fate Therapeutics
VistaGen Therapeutics and Excaliber Enterprises Announce Reverse Merger
ReNeuron Enters into Manufacturing Contract with NHS Blood and Transplant for Next-generation Stem Cell Product
Cellular Dynamics Licenses Technology from ViaCyte
US$ 6 Million Raised for New Cord Blood Bank in Australia
Plasticell Spins Out Regenerative Drug Discovery Venture
Sanofi-Aventis Completes Acquisition of Genzyme Corporation
International Stem Cell Corporation Receives Essential Approvals for Production of Parthenogenetic Stem Cell Lines in the United States
Yissum and Hadasit License Regenerative Polymeric Membrane Implants to RegeneCure
Beike Biotechnology to Upgrade Processing and Cryopreservation Technology to Expedite Advancements in Stem Cell Therapies
BioTime Acquires Glycosan to Merge with OrthoCyte
Indian and Californian Stem Cell Agencies Enter Agreement to Fund Collaborative Research Projects to Accelerate Regenerative Medicine towards Therapies
CIRM Enters into Stem Cell Research Agreement with ANR of France
Pluristem Therapeutics Teams up with NYU Medical Center for Examining PLX Cells Application in Treatment of Diabetic Foot Ulcers
Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group
Stemline Licenses Brain Cancer Vaccine (Phase I and Phase 2 study) 
CellSeed in Association with LA BioMed Plans to Launch Joint Research Project on Regenerative Medicine Technology
Cord Blood Collection Center Inaugurated in Leicester, UK
Genzyme Completes Sale of Diagnostic Products Business to Sekisui Chemical Co. 
Kyoto University, iPS Academia Japan and iPierian in Global Licensing and Patent Assignment Agreement
Transposagen Inks a Non-Exclusive License Agreement with Cellular Dynamics International for Cross-Licensing Technologies for Induced Pluripotent Stem Cells
New Law Supports Advancement of Cord Blood Research
BioTime Acquires Assets of Cell Targeting, Inc. 
BioCells Inc. , a Business of Cord Blood America, to Store Dental Pulp Stem Cells in Argentina
Essen BioScience Establishes Subsidiary in Japan
Transposagen Enters into License Partnership with Cellular Dynamics International
Embryome Sciences Adopts New Corporate Identity
NeoStem and Progenitor Cell Therapy Achieve Merger
Angel Biotechnology Holdings PLC in Contract with Pathfinder Cell Therapy
Kiadis Pharma Enters Licensing Agreement with Hospira for Commercialization of ATIR™ in Asia and Europe
KCI Obtains License to GRAFTJACKET® of Wright Medical for Wound Care
EHSI Employs NASA’s Intrifuge Rotary Cell Culture System in China
ARC Associates with Other Research Institutions for Reinforcing Special Research Initiative
InnovaStem Granted Manufacturing License to Separate Stem Cells from Cord Blood
BioTime Signs an MTA with the University of California System for Developing Five Human Embryonic Stem Cell Lines
BioTime Asia Inks a Marketing Agreement with SGMT for Supplying ACTCellerate™ Cell Lines in China and Other Areas
FamilyCord and Hoag Hospital Collaborate for Cord Blood Storage
Cord Blood America to Acquire Stem Cell Storage Company CryoCell Mexico
Mesoblast Acquires Angioblast
Mesoblast and Cephalon to Commercialize Novel Therapeutic Products for Regenerative Medicine
Korean Supreme Court Regards Stem Cells as Medicine
Plasticell and UCB in Small Molecule Drug Agreement
Plasticell and Sigma-Aldrich in Development Collaboration for Innovative Turnkey Solutions to Stem Cell Research
Cell Cure Neurosciences, Hadasit Bio Holdings, and Teva Pharmaceutical Industries Enters into an Exclusive License Agreement
FATE Enters into a Partnership Contract with BD
Medistem Collaborates with General Biotechnology LLC for Supplying ERC to Leading Universities and Leading Organizations
Stemedica International Partners with AnC Bio Group
Cellectis Gains Assessment for Induced Pluripotent Stem Cell Technology from iPS Academia Japan
CIRM Funds $72 Million Towards Translation of Basic Discoveries into New Therapies, Recruit Stem Cell Leaders to California
Medistem Join Hands with General Biotechnology LLC for Endometrial Regenerative Cells
Cryo-Cell Enters Industry-Exclusive Agreement with MedTech for Solutions, Inc. , A Group Purchasing Organization
Cord Blood America Enters into Agreement with the Hawaii Medical Service Association
Cord Blood America Completes Acquisition of BioCells
RTI Biologics and Athersys Enter Orthopedic Collaboration
Roslin Cells and Lonza in Development Collaboration for Pluripotent Stem Cell Media
First Indian Dual-Facility Cord Blood Bank Commences Operations
Stem Cell Facility Set up by Apollo Hospitals
Beike Biotechnology Establishes First Chinese Rehabilitation Center in Romania
Vitro Ties Up with Mokshagundam for Developing Cell Culture Medium
BioTime Establishes a New Subsidiary, OrthoCyte Corporation, for developing Stem Cell Technology based therapeutics for Orthopedic Disorders
STEMCELL Technologies Signs agreement with Stanford University
NIH Approves Advanced Cell Technology\'s Stem Cell Line for Federal Funding
Promega Enters into Partnership with Cellular Dynamics for the Validation of Stem Cell-Based In Vitro Assays
Thermogenesis Announces Divestiture of Cryoseal® Product Line
Shenzhen Beike Biotechnology and SiriCell Technologies Form Beike Holdings Limited, a Strategic Joint Venture for Stem Cell Therapies
Lifeforce Cryobanks TakesOver Cryobanks International’s Assets
Beike Biotechnology Expands Capacity
Cellular Dynamics Signs License Agreement with iPS Academia Japan
BioTime Acquires ES Cell International
Cytori Presents Study Report on Application of Stem & Regenerative Cells derived from Body Fat in Enhancing Heart Function in Chronic Ischemia Trial
Cryo-Save Enters into a Deal with Mutua Madrilena
Mesoblast Buys US based Angioblast Systems Inc. 
International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing
genOway and Griffith University Enters into Research Partnership
International Stem Cell Corporation and the Automation Partnership Enters into Agreement to Automate Cornea Tissue Production
Thermogenesis Announces Global Res-Q Distribution Agreement with GE Healthcare
Novocell Adopts New Identity
Axiogenesis Secures Yamanaka Patent Portfolio
Fate Acquires Ontario based Verio Therapeutics to Boost Offerings in Stem Cell Modulator Range
ThermoGenesis Signs Asia Distribution Agreement with Fenwal for Bioarchive and AXP Systems
ReNeuron Signs Manufacturing Contracts with Angel Biotechnology
Axiogenesis Signs Worldwide Distribution Contract with Lonza Cologne
ThermoGenesis Announces Major Strategic Development with Completion of New Distribution Agreement with GE Healthcare
Stem Cell Therapy International and Histostem Merge to form AmStem International
First Cord Blood Processing and Cryopreservation Facility in Philippines Opened
Canadian Cord Blood Bank - Lifebank Achieves FACT Accreditation
China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank
CORD:USE Cord Blood Bank and Memorial Healthcare System Enter Collaboration
Cord Blood America Signs Contract with BioE
ISCO Progresses Towards Establishment of the Industry’s First Universal Stem Cell Bank, UniStemCell™
BioTime Supplies Stem Cell Research Products to Millipore for Global Marketing of ACTCellerate™ Progenitor Cell Lines
Cryo-Save Successfully Completes Cord Blood Expansion Project
Athersys Signs Worldwide Agreement with Pfizer
Angel Biotechnology Receives Contract to Provide Regenerative Medicine Development Services
Celling Technologies Collaborates with Tissue Genesis for Prospective Incorporation of Adipose Tissue Stem Cell Technology in the area of Regenerative Medicine
Beike Biotechnology Invests Biomaster Inc. 
Stem Cell Therapy International and Histostem of Korea Provide Hematopoietic Stem Cell to Queen Mary Hospital, Hong Kong
CordLife to Expand its Indian Network
STEMSOFT Software Inc. , Licenses StemLab® Software to Cord Blood America
Pfizer Takes Over Stem Cell Therapies Assets of Axordia
International Stem Cell Signs Collaboration Agreement with Scripps Research Institute’s Center
HSCI Co-operates with Novartis
VetCell is UK\'s First Official Equine Stem Cell Centre
Cryo-Cell Licenses C`elle SM Technology to Cryopraxis Cryobiology
Gamida Cell Associates with Cellerix for Undertaking a Prospective Research
International Stem Cell and Absorption Systems Enters into Collaboration
Bioheart Makes Remarkable Medical Breakthrough with Stem Cells Obtained from Fat Tissue
California Stem Cell Enters into Collaboration with Stemina Biomarker Discovery
Bristol-Myers Squibb wholly Acquires Medarex
BrainStrom Signs Agreement with Harlan Biotech
Angel Enters Manufacturing Contract for Second-generation CTX Stem Cell Product with ReNeuron
Angel Biotechnology Enters into GMP Manufacturing Contract with Azellon Ltd. / University of Bristol
Novartis Takes Over Stem Cell Technology from Opexa
Expansion of Agreement between Cellular Dynamics International and Roche Pertaining to existing Cardiotoxicity Screening
LifeCell International Launches Cord Tissue Banking Service in Madurai
Neuralstem Deals with Taiwan based China Medical University for Developing Stem Cell Stroke Therapy
Takara Bio Inc. to supply RetroNectin® to U. S. and Europe for Multicentre Clinical Trials
GE Healthcare and Geron Announce Exclusive Global Agreement to Commercialize Stem Cell Drug Discovery Technologies
MaRS and SLRI Co-Operate on Marketing of Umbilical Cord Stem Cell Technology for Potential Treatment in Various Diseases
REMEDI Introduces PurStem
Cellular Dynamics In-Licenses Key Patent Collection
Advanced Cell Technology Licenses Single Blastomere Technology to CHA Bio & Diostech Co. , Ltd. , 
ENKAM Pharmaceuticals A/S Enters into Partnership with STEMCELL Technologies
Cytori Collaborates with GE Healthcare for StemSource Products Marketing in the US
StemCells Inc. , Signs License Agreement with Key Pharmaceutical Company
Cellartis and ReproCELL Enter into Marketing Agreement to facilitate Cardiotoxicity Screening Service using hESC Derived Cardiomyocytes
StemCells Inc. , Takes Over Stem Cell Sciences plc
China Lays Foundation for Comprehensive Stem Cell Storage and Processing Facility
University of Utah’s Cell Therapy Lab Enters into Collaboration with Q Therapeutics for ALS
ISCO Enters into Agreement with Cytograft Tissue Engineering to Develop Therapeutic Medium for Cytograft’s Living Vascular Grafts
Epistem Enters into R&D Agreement with Novartis
ArunA Biomedical Enters into Distribution Agreement with Neuromics
ISSCR Excited for Future of Human Embryonic Stem Cell Research after Withdrawal of Funding Ban
AstraZeneca and Cellartis Extends Collaboration to Develop Innovative Drug Safety Testing
Cellartis Signs License Agreement for Commercialization of hES cell production With ITI life sciences
Parkwayhealth and Mesoblast to Provide Stem Cell Products
License Agreement between Cellartis and WARF for Human Embryonic Stem Cells
PerkinElmer and VRI™ Enters into an Agreement with M. D. Anderson Cancer Center for Extending the Research Collaboration
Intercytex Acquires Stem Cell Company Axordia Limited
ReNeuron Enters into License Agreement with Bio Focus DPI
VistaGen and Capsant Enters into Commercial Agreement for Stem Cell Technology
Novocell Enters into Collaboration with Shinya Yamanaka of Kyoto University
VistaGen and WARF Signs License Agreement for Human Embryonic Stem Cell Technology
VistaGen Receives Stem Cell Tools and Technologies Grant from California Institute for Regenerative Medicine
BioCell and Cellsense Merge
Joint Venture of Advanced Cell Technology and CHA Biotech named Stem Cell & Regenerative Medicine International
Cellular Dynamics International Amalgamates Sister Concerns
Cellular Dynamics International Receives Finance of US$500,000
Collaboration between Cellartis, Novo Nordisk and Lund University for development of insulin-producing cells from stem cells
ESI Join Hands with a major Pharma company for evaluation of GMP-Grade Stem Cell Lines
STEMCELL Technologies Launches AggreWell™ 400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
International Stem Cell Corp. , and Novocell Enters into Collaboration for Treatment Solutions for Diabetes
GlaxoSmithKline Co-operates with Harvard Stem Cell Institute in the Area of Stem Cell Science
Angel Biotechnology and Angport in pre-GMP Development Program Contract
International Stem Cell Corp. , Enters into Agreement with Biotime and Embryome Sciences for Human Stem Cell Line Research
VivoMedica plc and Cellartis AB Enters into Collaboration for hESC Research
MedCell and NovaThera Merge for Musculoskeletal Regeneration
Angel Biotechnology and Novolytics in GMP Contract for Phase I/II clinical trials
ReNeuron Enters into Contract Agreement with Angel Biotechnology
WARF Grants License to Invitrogen for Research with Karyotypically Normal Human Embryonic Stem Cell
New Business Enterprise Formed to Develop Treatment with Adult and Cord Blood Stem Cells
KCI Acquires LifeCell for $1. 7 Billion in Cash
Osiris in Sale Agreement with NuVasive for Osteocel®
ImmuneRegen® Joins with BioCure for Developing New Wound-Healing Therapy
International Stem Cell Corporation Receives Exclusive Rights for Supplying Artificially Developed Human Skin Models
UCSD Joins consortium of Institutions for Research on Regenerative Technologies
Queensland gets a New Stem Cell Research Facility
Cordlife Ltd. Granted License to Establish New Cord Blood Stem Cells Bank in India
Asia-Cryo Cell Renamed as LifeCell International
Pentagon to Partially Finance a New Research on Regeneration of Limbs
CordLife Launches Largest Southeast Asian Cord Blood Bank in Singapore
MediHealth and NovaThera in Manufacturing and Marketing Agreement for NovaPod™
VistaGen Therapeutics in Stem Cell R&D Alliance with University Health Network of Toronto and the McEwen Centre for Regenerative Medicine
Stem Cell Therapy International Plans Merger with Histostem
Cellartis and Pfizer in Research Collaboration for Development of Screening System to Detect Human Toxicity
Angioblast and Abbott in Heart Therapy Collaboration
Angel Biotechnology Enters into New GMP Manufacturing Contract
Osiris Therapeutics Reclaim Worldwide Rights to Prochymal™
BrainStorm and Rutgers University to Develop Spinal Cord Injury Therapy in Collaboration
StemCells, Inc. and Casey Eye Institute in Research Collaboration
Osiris Obtains $224. 7 Million Department of Defense Contract for Prochymal™
4. Major Product Innovations/Launches
Sceil: A Chance for People to Convert Adult Cells into Stem Cells and Store them
Phase III Study (MM-020/IFM 07-01) of Oral REVLIMID (Lenalidomide) in Recently Detected Multiple Myeloma Meets the Initial Conclusion
Stemedica Progress to Phase II Stroke Trial with Lead Product Stemedyne-MSC
Takara Bio Releases Nippi’s iMatrix-511 to Facilitate Growth of Human Stem Cells
US FDA Grants Orphan Drug Designation to Verastem’s Defactinib
Life Technologies Introduces Industry\'s First Stem Cell Characterization Panel
CSIRO Develops Test to Improve Stem Cell Safety
StemCells Spinal Cord Injury Trial Approved by Health Canada
Thermo Fisher Scientific Broadens Stem Cell Media Products - HyCell- STEM and HyCell-STEM-FF Systems
Phase 1 Clinical Trial of FAK Inhibitor VS-4718 in Patients with Advanced Cancer
Cellular Dynamics International Widens MyCell Product Line with Disease Models, and Genetic Engineering Patents
The European Commission Provides Orphan Medicinal Product Designation to Verastem’s VS-6063 in Mesothelioma
Life Technologies Launches a New Range of Stem Cell Reprogramming Solutions
BioTime and LifeMap Sciences Releases Improved LifeMap BioReagents Portal
LifeMap Sciences in Association with ProSpec-Tany TechnoGene Expands Product Line
MHRA Approves Expansion of Phase II Clinical Trial for MultiStem® Cell Therapy of Athersys in Ischemic Stroke
Harvard Apparatus Regenerative Technology\'s \"InBreath\" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea
Regen BioPharma Files Investigational New Drug Application for HemaXellerate I for Aplastic Anemia
Health Canada Approves Kiadis Pharma’s Phase II Clinical Study with its Blood Cancer Treatment ATIR™
ATIR™
Medipost to Launch Stem Cell Culture Cosmetics
FDA Approves Mesoblast’s Use for Clinical Trial Production of Proprietary Mesenchymal Precursor Cells in Singapore Manufacturing Facility
Kiadis Pharma Obtains U.S. Patent for its Blood Cancer Treatment ATIR™ Procedure
Cellular Dynamics Commences Production of Human iPSC Lines under cGMP Conditions
Biobest Announces the Launch of Quine Stem Cell Service marketed as Biobest Stem Cells
Thermo Fisher Scientific Adds Cryopreservation Reagents for Cell Culture Application
FDA Recommends Further Study for Gamida’s StemEx®
BioTime Isolates Seven Diverse Cartilage and Bone Cell Types from Human Embryonic Stem Cells
GE Healthcare and Cellular Dynamics International Accede to Sublicense for Cellular Assay Copyrights
US Patent to Axiogenesis for In-Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy
CIRM Grants more than $6 Million to UCLA Stem Cell Researchers
BioLife Solutions Announces TiGenix’s Completion of Stem Cells and HypoThermosol® Clinical Trial
UC Davis Dermatologist Receives Grant to Find New Method to Treat Chronic Skin Wounds
Stemedica Obtains US Patent for Stem Cell Treatment of Diabetic Retinopathy and Diabetic Optic Neuropathy
TiGenix Shuts Operations in Biomaterial Unit and Emphasizes on ChondroCelect and our Proprietary Adipose Derived Stem Cell Products
Positive Results from Phase 1/2 POSEIDON Trial Demonstrate Donor (Allogeneic) Adult Mesenchymal Stem Cells (MSCs) Utilizing BioCardia Catheter Delivery Sy Stem Are Similarly Effective as Patients’ Own Stem Cells in Treating Ischemic Heart Failure
LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches LifeMap Discovery™: A Database of Human Cellular Life for the Field of Regenerative Medicine
Cardio3 BioSciences to initiate the world’s first Phase III Clinical Trial in Regenerative Medicine for Heart Failure
Umbilical Cord Cells Demonstrates effective results than Bone Marrow Cells in Damaged Heart Repair
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch
Newborn Human Foreskin Fibroblasts qualified for iPSC reprogramming launched by AMSBIO
VistaGen Therapeutics Launches LiverSafe 3D that helps in Predictive Liver Toxicology and Drug Metabolism Bioassay System
Stem Cells Being Used as Therapy for Diabetes
Axiogenesis Launches Cor.4U Human iPS Cell-Derived Cardiomyocytes
The National Institutes of Health Grants Contract Worth $6.9 Million for iPS Cells to Cellectis bioresearch Inc. 
Sigma Life Science Launches Innovative, Affordable Pluripotent Stem Cell Culture Medium
Cellectis Stem Cells Launches Improved Format of Stem Cell Derived Cardiomyocytes
UC Davis Researcher Granted $1.3 million to Develop Bio-pacemaker from Stem Cells
CIRM Grants $37.3 Million to Assist UC Irvine Efforts
Store-A-Tooth™ Dental Stem Cell Banking Commits to \"Find a Cure\" for Type 1 Diabetes
Bio-Rad Launches TC20 Automated Cell Counter
Cellectis Stem Cells Launched New and Improved User Friendly Version of Stem Cell Derived Cardiomyocytes. 
AllCells Launches Autoimmune Diseased Cells and Tissue Products
Swissmedic Grants Import/Export License to Stemedica for Stemedyne™ Stem Cell Line
Huntington\'s disease Research Fueled by $19 Million from CIRM
Advanced Bio Healing is Shire Regenerative Medicine Now
$14 million Grant to UC Davis for Stem Cell Research in Vascular Disease to Accelerate Therapy to Critical Limb Ischemia (CLI) Patients
Asahi Kasei Medical Co Decides to purchase Cryoseal® Product Line from ThermoGenesis
International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology
U-M Makes Six New Stem Cell Lines Available for Research
HemoGenix® FDA Master File to Measure Blood Stem Cell Potency for Cellular Therapy Products
HemoGenix® Launches the Largest Roll-Out of New Assays in its 11 Year History
ReproCell Launches Alzheimer’s Disease Model Based on iPS-derived Human Neuronal Cells
Prochymal, a Life-Saving Stem Cell Drug of Osiris, Granted Marketing Approval in New Zealand
Beike Receives AABB Accreditation for Storing Cord Blood and Cord Tissue
International Stem Cell Corporation Announces New Stem Cell Manufacturing Technologies to Support is Therapeutic Programs
iPierian Advances Monoclonal Antibody Drug Development Programs Targeting Tau protein and the Complement Sy Stem for the treatment of Neurodegenerative Diseases. 
Stemedica International and its Academic Partner Awarded Swiss Alzheimer’s and Stem Cell Research Grant
USC Stem Cell Research Lands $ 1.75 Million Grant
Cellectis Stem Cells Launches Globally First Human iPS Cell-derived Hepatocyte Product
VistaGen Obtains Important US Patent that Covers Stem Cell Technology Procedures that are Used to Test Drug Candidates for Liver Toxicity
Second U-M Stem Cell Line Made Available to Researchers to Find Treatment for Nerve Condition
VistaGen obtains license for advanced Stem Cell Culture Technology to Expedite development of Drug Screening and Cell Therapy for disorders of the Immune System
Roslin Cells to Manufacture iPS Cells for Bipolar Disorder Research
BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis Proposed Trial Will Build on NurOwn™ Platform to Meet Unmet Needs of Patients with Neurodegenerative Disorders
Researchers from Ottawa to Lead Globally-First Clinical Trial of Stem Cell Therapy for Septic Shock
BioVision, Inc. releases StemBoost™ \"Ready-to-Use\" cocktails for Stem Cell Research
U-M Human Embryonic Stem Cell Line Placed on National Registry
Nanotube Treatment Is now tried on Breast cancer Stem Cells
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Stemedica Granted US Patent for Cellular Scaffold
Amorcyte, a Neo Stem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction
Faculty Members of University of Toronto Perform First Cardiac Stem Cell Transplant in Ontario
High Impact Research Projects at uOttawa Receive $1.9 Million Funding
BioTime to Manufacture Stem Cells for Research in Muscle Disorders
Cryo-Save India Awarded AABB Accreditation
Mesoblast Receives FDA Clearance for Phase 2 Clinical Trial of the Proprietary Stem Cell Therapy in Type 2 Diabetes
Cellular Dynamics Commercially Launches iCell® Neurons for Neuroscience Drug Discovery
Cytori\'s Celution® One Sy Stem Awarded European CE Mark
First Stem Cell Bandage in Human Clinical Trials
FDA Approves First Cord Blood Transplant for Stem Cell Therapy
PerkinElmer’s Viacord® Cord Blood Banking Business to Expand Cell Harvesting Capabilities
Regulatory Clearance to Mesoblast for First Phase II Clinical Trial for Eye Diseases
Vitro Develops Stem Cell Technology for Hearing Impairment Treatment
Cytolon Commences Global Development of DIT - Distributed-Inventory-Technology™
StemCells, Inc Announces World’s First Neural Stem Cell Transplant in Patient with Spinal Cord Injury
ACT Receives Approval to Conduct First Human Embryonic Stem Cell Trial Analysis in Europe
VistaGen Therapeutics Receives Two Stem Cell Technology Patents
Cellular Dynamics Launches iCell® Endothelial Cells for Vascular-targeted Drug Discovery
ReN001 Stem Cell Therapy of ReNeuron Approved by DSMB for Higher Dose in Clinical Trial for Stroke
NIH Approves for Four GMP Human Embryonic Stem Cell Lines of BioTime
Stem Cell Therapeutics Obtains Patent for Vital Stem Cell Technologies with Expanded Geographic Coverage
Grant of Two Stem Cell Technology Patents Expands Patent Portfolio and Geographic Coverage of Stem Cell Therapeutics Corp. 
Vitro Launches Latest Stem Cell Products
BioTime Issued Second U.S. Glycosan Hydrogel Patent
Data Monitoring Committee Approves Continuation of Phase III Clinical Study of StemEx®
Simple Method to Detect Breast Cancer at \'Stage 0\' Discovered
International Stem Cell Corporation Begins Series of Preclinical Animal Studies of Neuronal Cells Derived From Human Parthenogenetic Stem Cells
International Stem Cell Corporation Innovates Method for Generation of Uncontaminated Liver Cells
Medi Stem Licensee RenovoCyte LLC Granted FDA INAD for Universal Donor Endometrial Regenerative Cells or ERC
TAP Biosystems to Launch New Automated Cell Culture and Maintenance Sy Stem for Stem Cell Research
Highly Effective Stem Cell Reprogramming Technology Has Been Introduced By Life Technologies Corporation
PerkinElmer’s ViaCord® Family Cord Blood Banking Business Announces First and Only Service to Bank Stem Cells Harvested from Umbilical Cord Tissue
Apollo Bramwell Hospital Launches Stem Cell Therapy Program
Cryo-Cell Launches New Service and Exclusive Family Healthcare Protection Plan
BrainStorm’s NurOwn™ Receives Ministry of Health Approval to Conduct First Clinical Trial Adult Stem Cell Therapy for ALS
TAP Biosystems’ CompacT SelecT™’s Innovative Options
Americord Registry Launches “Bank One, Give One” Cord Blood Program
Stempeutics Obtains Regulatory Approval to Conduct Clinical Trials in Malaysia
StemCells, Inc. Adds Serum-Free and Animal Component-Free Culture Supplements to its SC Proven(R) Product Portfolio
LifeCell Brings Menstrual Blood Stem Cell Banking to India
LifeCell International Launches Femme
StemCells Introduces Novel Purified Whole Cell Lysate Reagents to Proprietary SC Proven® Product pipeline
First Neural Stem Cell Study for Spinal Cord Injury Commenced
Vet-Stem’s Canadian Licensee Avivagen Delivers Stem Cell Therapy
HemoGenix® Launches LumiCYTE™-HT, a Contract Services In Vitro Hepatotoxicity Screening Platform
HemoGenix® Launches STEMpredict™
Life Technologies Receives FDA 510(K) Clearance for Stem Cell Growth Medium
Advanced Cell Technology Obtains Patent to Synthesize Embryonic Stem Cells without Embryo Destruction
NIH Re-evaluates and Approves Human Pluripotent Stem Cell Lines of Cellartis
Lonza and CSC Launches MotorPlate™ Human Esc-derived Motor Neuron Progenitors
UTHealth and Athersys Researchers Unveil the Preclinical Data Report Demonstrating Prospective Advantages of MultiStem® for Stroke Therapy
StemCord Receives Highest Cord Banking Accreditation
TAP Unveils CellBase CT™ for Advancing Ex-Vivo Expansion of Autologous Cell Therapies
Stempeucel from Stempeutics Cleared DCGI Application for Phase II Clinical Analysis
First HuCAL-based Antibody to Target Cancer Stem Cells in Clinical Trial
Aldagen Receives FDA Clearance for ALD-401
Advanced Cell Technology Obtained FDA Clearance to Treat Age-Related Macular Degeneration (AMD) 
Geron Initiates Randomized Phase 2 Clinical Trial of Imetelstat
Stem Cell Therapeutics Corp. Receives Patent Associated with NTx® - 265
EHSI: Celulas Genetica Obtains Patent for their Ground Breaking Stem Cell Treatment
Arteriocyte Launches NANEX™
Medtronic Acquires Osteotech
International Stem Cell Launches Stem Cell based Range of Skin Care Products
AllCells Expands its Portfolio of Primary Adult Stem Cell Products
Geron Begins Clinical Trial of Human Embryonic Stem Cell-Based Therapy
SANYO Unveils an Exclusive Stand-Alone Cell Processing Work Station
Absorption Systems Obtains Patent for CellPort Technologies
BioCardia Declares Patent Issuance for Cardiac Regenerative Medicine using Stem Cell Therapy
Stemedica Completes Clinical Stem Cell Master Bank
Kansas-State University Receives Patent for Isolating, Culturing and Storing of Stem Cells
ReproCELL Launched Novel Services in Neuronal Research, Employing Human IPS Cells
FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the US
Mesoblast Obtains TGA Regulatory Approval to Commercially Manufacture Adult Stem Products
Am Stem Initiates US Study of Flagship Cosmeceutical Facial Cream Product SteMixx
TAP Launches Automated Stem Cell Processing Range
Advanced Cell Technology Receives Patent for Production of Retinal Pigment Epithelial Cells
United States Patents and Trademark Office Approves International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent
New Cosmeceutical Beauty and Hair Restoration Products Launched by AmStem
FDA Grants Orphan Drug Designation to Osiris’ Stem Cell Treatment for Type 1 Diabetes
CCS Cell Culture Service GmbH Adopts the MaxCyte ® STX ™Scalable Transfection Sy Stem for Cell Line Development
Cryo-Save Introduces Novel Cryo-Lip® Stem Cell Storage Service
ViaCyte Inc., Receives Three Additional U.S. Patents, Supporting its Development of a Stem Cell Derived Treatment for Diabetes
StemCells Inc. Plans to Advance Second Clinical Trial in Batten Disease
Millipore Markets Advanced Scepter™ Handheld Automated Cell Counter Globally
Thermogenesis Extends Global Reach for Bone Marrow Products with New Distribution Agreements
International Stem Cell Corporation Initiates Second Pre-Clinical Phase Testing of Retinal Pigment Epithelium (RPE) 
Cord Blood Registry Introduces Industry-Leading Innovations for Newborn Stem Cell Collection
FamilyCord Launches Superior Cord Blood Collection Kit
Corning Unveils the Synthemax™ Surface for Application in Developing hESCs
Cellartis Launches Novel 2D Cardiomyocyte Product
CordLife Launches Advanced Human Stem Cell Technology in Hong Kong
StemCells, Inc. Granted Broad Patent for Pluripotent Rat Stem Cells and Genetically Engineered Rats
StemCells Introduces Cell Culture Medium
Fate Therapeutics Receives Patent for Induced Pluripotent Stem Cell Technology
USPTO Grants Patent to Athersys for Adult Stem Cell Composition & Production
Geron Undertakes Study for Analyzing the GRNOPC1 Effectiveness in Alzheimer\'s Disease Models
StemCells Launches First Cell Culture Medium
Cellular Dynamics Launches iCell™ Cardiomyocytes for Drug Candidate Toxicity Screening
Stem Cells Strengthens Patent Position in Embryonic and Induced Pluripotent Stem cell Technology Platforms
Embryonic and Induced Pluripotent Stem Cell Technology Platforms of StemCells Inc., further Reinforced
Mesoblast’s Trial Demonstrates Successful Results in Bone Marrow Regeneration in Cancer Patients empl

List of Chart


Exhibit 1.Evolution of Stem Cell Research
Exhibit 2.Segmentation of Global Stem Cells Market by Stem Cell Type, Technology & Therapeutic Area
Exhibit 3.Stem Cell Research – Global Market Estimations & Predictions (2005 -2020) in US$ Million  (Graphical Representation Included) 
Exhibit 4.List of Global Major Stem Cell Companies
Exhibit 5. Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 6. Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 7. Stem Cell Research - Global Investments (2005 -2020) in US$ Million (Graphical Representation Included) 
Exhibit 8. Stem Cell Research – North American Market Estimations & Predictions (2005 - 2020) in  US$ Million for United States and Canada (Graphical Representation Included) 
Exhibit 9. Stem Cell Research – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 
Exhibit 10. Stem Cell Research - United States Investments (2005 – 2020) in US$ Million (Graphical Representation Included) 
Exhibit 11. List of Cord Blood/ Stem Cell Banks in the United States
Exhibit 12. List of Cord Blood/ Stem Cell Banks in Canada
Exhibit 13. List of Major North American Stem Cells Companies
Exhibit 14. Stem Cell Research – European Market Estimations & Predictions (2005 - 2020) in US$ Million for United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe (Graphical Representation Included) 
Exhibit 15. Stem Cell Research – European Market Shares (2010, 2015 & 2020) for United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe (Graphical Representation Included) 
Exhibit 16. List of Cord Blood/ Stem Cell Banks in the UK
Exhibit 17. List of Cord Blood/ Stem Cell Banks in Germany
Exhibit 18. List of Cord Blood/ Stem Cell Banks in France
Exhibit 19. List of Cord Blood/ Stem Cell Banks in Spain
Exhibit 20. List of Cord Blood/ Stem Cell Banks in Russia
Exhibit 21. List of Cord Blood/ Stem Cell Banks in Switzerland
Exhibit 22. List of Major European Stem Cells Companies
Exhibit 23. Stem Cell Research – Rest of Europe Market Estimations & Predictions (2005 - 2020) in US$ Million for Belgium, Denmark, Poland, Austria and Greece (Graphical Representation Included) 
Exhibit 24. Stem Cell Research – Rest of Europe Market Shares (2010, 2015 & 2020) for Belgium, Denmark, Poland, Austria and Greece (Graphical Representation Included) 
Exhibit 25. List of Cord Blood/ Stem Cell Banks in Rest of Europe
Exhibit 26. Stem Cell Bank in Denmark
Exhibit 27. List of Cord Blood/ Stem Cell Banks in Poland
Exhibit 28. List of Cord Blood/ Stem Cell Banks in Austria
Exhibit 29. List of Cord Blood/ Stem Cell Banks in Greece
Exhibit 30. Stem Cell Research – Asia-Pacific Market Estimations & Predictions (2005 - 2020) in US$ Million for Japan, India, China, Australia, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 
Exhibit 31. Stem Cell Research –Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, India, China, Australia, South Korea and Rest of Asia-Pacific (Graphical Representation Included) 
Exhibit 32. List of Cord Blood/ Stem Cell Banks in Japan
Exhibit 33. List of 11 Cord Blood Banks that forms Japan Cord Blood Bank Network (JCBBN) 
Exhibit 34. List of Cord Blood/ Stem Cell Banks in India
Exhibit 35. List of Cord Blood/ Stem Cell Banks in China
Exhibit 36. List of Cord Blood/ Stem Cell Banks in Australia
Exhibit 37. List of Cord Blood/ Stem Cell Banks in South Korea
Exhibit 38. List of Major Asia-Pacific Stem Cells Companies
Exhibit 39. Stem Cell Research – Rest of Asia-Pacific Market Estimations & Predictions (2005 - 2020) in US$ Million for Hong Kong, Taiwan, New Zealand, Malaysia and Singapore (Graphical Representation Included) 
Exhibit 40. Stem Cell Research – Rest of Asia-Pacific Market Shares (2010, 2015 & 2020) in US$ Million for Hong Kong, Taiwan, New Zealand, Malaysia and Singapore (Graphical Representation Included) 
Exhibit 41. List of Cord Blood/ Stem Cell Banks in Rest of Asia-Pacific
Exhibit 42. List of Cord Blood/ Stem Cell Banks in Hong Kong
Exhibit 43. List of Cord Blood/ Stem Cell Banks in Taiwan
Exhibit 44.Cord Blood Bank in New Zealand
Exhibit 45. List of Cord Blood/ Stem Cell Banks in Singapore
Exhibit 46. Stem Cell Research – Rest of World Market Estimations & Predictions (2005 - 2020) in US$ Million for Latin America, Middle East and South Africa (Graphical Representation Included) 
Exhibit 47.Stem Cells– Rest of World Global Market Shares (2010, 2015 & 2020) for Latin America, Middle East and South Africa (Graphical Representation Included) 
Exhibit 48. List of Major Companies in Rest of World
Exhibit 49. Stem Cell Research – Latin American Market Estimations & Predictions (2005 - 2020) in US$ Million for Brazil, Colombia, Mexico, Argentina and Rest of Latin America (Graphical Representation Included) 
Exhibit 50. Stem Cell Research – Latin American Market Shares (2010, 2015 & 2020) by for Brazil, Colombia, Mexico, Argentina and Rest of Latin America (Graphical Representation Included) 
Exhibit 51. List of Cord Blood/ Stem Cell Banks in Mexico
Exhibit 52. List of Cord Blood/ Stem Cell Banks in Brazil
Exhibit 53.Cord Blood Bank in Colombia
Exhibit 54. List of Cord Blood/ Stem Cell Banks in Argentina
Exhibit 55. Cord Blood/ Stem Cell Banks in Rest of Latin America
Exhibit 56. Stem Cell Research – Middle East Market Estimations & Predictions (2005 - 2020) in US$ Million for Israel and Rest of Middle East (Graphical Representation Included) 
Exhibit 57. Stem Cell Research –Middle East Market Shares (2010, 2015 & 2020) by for Israel and Rest of Middle East (Graphical Representation Included) 
Exhibit 58. List of Cord Blood/ Stem Cell Banks in Israel
Exhibit 59. List of Cord Blood/ Stem Cell Banks in Rest of Middle East
Exhibit 60. List of Cord Blood/ Stem Cell Banks in South Africa
Exhibit 61. Stem Cells by Type – Global Market Estimations & Predictions (2005 -2020) in US$ Million for Adult Stem Cell, Cord Blood Stem Cells, Embryonic Stem Cells and Other (Graphical Representation Included) 
Exhibit 62. Stem Cells by Type – Global Market Shares (2010, 2015 & 2020) for Adult Stem Cell, Cord Blood Stem Cells, Embryonic Stem Cells & Other (Graphical Representation Included) 
Exhibit 63. Adult Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 64. Adult Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 65. Adult Stem Cell Research - Global Investments (2005 -2020) in US$ Million (Graphical Representation Included) 
Exhibit 66. Human Adult Stem Cell Research - United States Investments (2005 -2020) in US$ Million (Graphical Representation Included) 
Exhibit 67. List of Major Global Adult Stem Cells Companies
Exhibit 68. Cord Blood Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 69. Cord Blood Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 70. Autologous Cord Blood Stem Cell – Global Market Shares (2009) by Therapeutic Application (Graphical Representation Included) 
Exhibit 71. List of Major Global Cord Blood Stem Cells Companies
Exhibit 72. Embryonic Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 73. Embryonic Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 74. List of Major Global Embryonic Stem Cells Companies
Exhibit 75. Other Stem Cell Research – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 76. Other Stem Cell Research – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 77. Stem Cells by Technology – Global Market Estimations & Predictions (2005 -2020) in US$ Billion for Stem Cell Transplantation, Cell based Genomics, Xenotransplantation,  Cord Blood Banking and Other (Graphical Representation Included) 
Exhibit 78. Stem Cells by Technology – Global Market Shares (2010, 2015 & 2020) for Stem Cell Transplantation, Cell based Genomics, Xenotransplantation, Cord Blood Banking & Other (Graphical Representation Included) 
Exhibit 79. Stem Cell Transplantation – Global Market Estimations & Predictions (2005 - 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 80. Stem Cell Transplantation – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 81. List of Major Global Stem Cell Transplantation Companies
Exhibit 82. Cell based Genomics – Global Market Estimations & Predictions (2005 - 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 83. Cell based Genomics – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 84. Xenotransplantation – Global Market Estimations & Predictions (2005 - 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 85. Xenotransplantation – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 86. Cord Blood Banking by Geographic Region – Global Market Estimations & Predictions (2005 - 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 87. Cord Blood Banking by Geographic Region – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 88. Cord Blood Banks – Global Market Shares (2012) by Geographic Region (Graphical Representation Included) 
Exhibit 89. Private Cord Blood Banks – Global Market Shares (2012) by Geographic Region (Graphical Representation Included) 
Exhibit 90. Public Cord Blood Banks – Global Market Shares (2012) by Geographic Region (Graphical Representation Included) 
Exhibit 91. Other Stem Cell Technologies – Global Market Estimations & Predictions (2005 - 2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 92. Other Stem Cell Technologies – Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 93. Stem Cells by Therapeutic Area – Global Market Estimations & Predictions (2005 -2020) in US$ Million for Neurology, Orthopedics, Oncology, Hematology, Cardiology, Dermatology, Diabetes, Hepatology and Other (Graphical Representation Included) 
Exhibit 94. Stem Cells by Therapeutic Area – Global Market Shares (2010, 2015 & 2020) by Therapeutic Area for Neurology, Orthopedics, Oncology, Hematology, Cardiology, Dermatology, Diabetes, Hepatology and Other (Graphical Representation Included) 
Exhibit 95. Stem Cells in Neurology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 96. Stem Cells in Neurology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 97. List of Major Global Stem Cells in Neurology
Exhibit 98. Stem Cells in Orthopedics – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 99. Stem Cells in Orthopedics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 100. List of Major Global Stem Cells in Orthopedics Companies
Exhibit 101. Stem Cells in Oncology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 102. Stem Cells in Oncology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 103. List of Major Global Stem Cells in Oncology Companies
Exhibit 104. Stem Cells in Hematology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 105. Stem Cells in Hematology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 106. List of Major Global Stem Cells in Hematology Companies
Exhibit 107. Stem Cells in Cardiology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 108. Stem Cells in Cardiology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 109. List of Major Global Stem Cells in Cardiology Companies
Exhibit 110. Stem Cells in Dermatology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 111. Stem Cells in Dermatology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 112. List of Major Global Stem Cells in Dermatology Companies
Diabetes
Exhibit 113. Stem Cells in Diabetes – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 114. Stem Cells in Diabetes – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 115. List of Major Global Stem Cells in Diabetes Companies
Exhibit 116. Stem Cells in Hepatology – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 117. Stem Cells in Hepatology – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 118. List of Major Global Stem Cells in Hepatology Companies
Exhibit 119. Stem Cells in Other Therapeutics – Global Market Estimations & Predictions (2005 - 2020) in US$ Million by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 120. Stem Cells in Other Therapeutics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 
Exhibit 121. List of Sources for Allogeneic Stem Cell Transpl

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *